(Q43872644)

English

Clinical evaluation of the Vitek automated system with cards GNS 122 and 127 and VTK-R07.01 software for antimicrobial susceptibility testing of Pseudomonas aeruginosa

scientific article published in January 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical evaluation of the Vitek automated system with cards GNS 122 and 127 and VTK-R07.01 software for antimicrobial susceptibility testing of Pseudomonas aeruginosa (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Pseudomonas aeruginosa

1 reference

based on heuristic

inferred from title

author name string

Chandler LJ

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Poulter M

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Reisner B

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Woods G

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Diagnostic Microbiology and Infectious Disease

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

71-73

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Critical evaluation of the Vitek GNS F6 card results compared to standardized, reference susceptibility test methods

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900309-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of the Vitek system to accurately test the susceptibility of Pseudomonas aeruginosa clinical isolates against cefepime

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900309-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Antimicrobial activity and spectrum investigation of eight broad-spectrum beta-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Cefepime Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900309-1

7 January 2021

based on heuristic

inferred from DOI database lookup

In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.

1 reference

https://api.crossref.org/works/10.1016%2FS0732-8893%2801%2900309-1

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0732-8893(01)00309-1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43872644&oldid=2105501929"